Inflammatory Bowel Disease Monitor is an independent journal published by Remedica Medical Education and Publishing. Each issue features in-depth review articles, written by practicing specialists, discussing current and emerging topics of clinical interest (our "Leading Articles"). These articles are commissioned according to relevant themes identified by the Editors-in-Chief, Clinical Editors, Editorial Advisory Board, and readers. We also present an ongoing, systematic review of key articles selected from the recent international literature (our "Clinical Reviews", written by the Clinical Editors), alongside case studies and reports from the major international meetings.
Editorial control is the responsibility of the Editors-in-Chief, Editorial Advisory Board, Clinical Editors, and the publisher. Before publication, all material submitted to the journal is subjected to rigorous review by the Editors-in-Chief, Editorial Advisory Board, Clinical Editors, and/or independent reviewers for suitability of scientific content, scientific accuracy, scientific quality, and conflict of interest.
Correspondence
We look forward to receiving your suggestions for content that deserves to be featured, and on any matter that might improve the journal.
Please address all correspondence to:
Remedica Medical Education and Publishing Ltd., Commonwealth House, 1 New Oxford Street, London, WC1A 1NU, UK.
Tel: +44 (0)20 7759 2999 Fax: +44 (0)20 7759 2951
Email: info@remedicajournals.com
Editor: Rhian Phillips, PhD
Editorial Assistant: Simon Worsley
Production Controller: Marie Ingram
Editorial Manager: Scott Millar
Publishers: Ian Ackland-Snow, Simon Kirsch
Design and Artwork: AS&K Skylight Creative Services
ISSN: 1466-7401 (Print)
ISSN: 2040-3909 (Online)
Produced and published by Remedica Medical Education and Publishing Limited.
Publisher's Statement
2010 Remedica Medical Education and Publishing.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. Inflammatory Bowel Disease Monitor is published four times a year. Additional subscription information is available from the publisher.